Bamlanivimab

Monoclonal antibody developed for the treatment and prevention of COVID-19.

Etesevimab

Monoclonal antibody developed specifically to combat COVID-19.

Casirivimab

A monoclonal antibody developed as a therapeutic intervention against COVID-19

Imdevimab

Monoclonal antibody formulated to combat COVID-19 by specifically targeting the spike protein of the SARS-CoV-2 virus.

Sotrovimab

Monoclonal antibody developed for treatment of COVID-19. Designed to bind to the spike protein of the SARS-CoV-2 virus

Adalimumab

Monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α) By inhibiting TNF-α, adalimumab helps reduce inflammation

Cetuximab

Cetuximab is a monoclonal antibody used in cancer treatment.

View

Denosumab

Monoclonal antibody that specifically targets and inhibits the receptor activator of nuclear factor kappa-B ligand (RANKL) reducing bone loss

Rituximab

monoclonal antibody that targets the CD20 protein found on the surface of B cells, treating non-hodgkin lymphoma